Award
NIH Reporter #1R43DK141421-01
Self-sealing needle guide system for reliable hemodialysis
Recipient
FLOWPOINT MEDICAL INC, OVERLAND PARK, KS, UNITED STATES
Award Amount
$324,836.00
Ceiling
$324,836.00
Awarded
September 17, 2024
Identifier
1R43DK141421-01
Award for developing a cutting-edge implantable device to improve vascular access for hemodialysis, aiming to reduce infection, bleeding, and incorrect needle placement risks, improving patient outcomes and cost-effectiveness.
Description
Development of an implantable vascular access device to improve safe and reliable cannulation for hemodialysis patients, enhancing quality of life and reducing healthcare costs.